Welcome Guest
Sign In
Register
Home
API
Manufacturing
Clinical Trials
Analytical Testing
Cold Chain
Articles
Facility Tours
News
Events
Videos
Clinical Trials Documentary
A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In
Home
API
Product and Service Directory
Clinical Trial Development Services and Outsourcing
Contract Research Organizations / Contract Research Services (CRO Services)
Preclinical Contract Research / Preclinical Research Services (Preclinical CRO)
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Drug Efficacy Testing and Modeling Services
Preclinical Pharmaceutical Screening Services
Preclinical Pharmacology Services by Therapy Type
Preclinical Cancer Pharmacology / Oncology Pharmacology Services
Preclinical Cardiovascular Pharmacology Services
Preclinical Diabetes Pharmacology Services
Preclinical Inflammation Pharmacology Services
Preclinical Multiple Sclerosis Pharmacology Services
News
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
Monday, August 03, 2026
Polpharma Biologics announced that the FDA and the EMA have accepted for review the Biologics License Application (BLA) and Marketing Authorization Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio® (vedolizumab) lyophilized...
read more
Codis Completes Nottingham Deal to Expand Europe’s Spray Dry Network
Monday, August 03, 2026
Codis has completed its acquisition of Catalent’s Nottingham, UK facility, a move that expands the company’s integrated spray dry offering in Europe and adds oral solid dose development and small-scale commercial manufacturing capabilities.
read more
Genezen, Raiden Science Foundation Partner on UBA5 Gene Therapy Manufacturing
Monday, August 03, 2026
Genezen and the Raiden Science Foundation have announced a manufacturing partnership for an AAV9 gene replacement therapy for UBA5 disorder, moving the program closer to a first-in-human clinical trial.
read more
Resilience and Lilly Invest $750M to Increase U.S.-Manufactured Medicine Supply
Monday, August 03, 2026
Resilience announced it has expanded its strategic partnership with Eli Lilly and Company to increase U.S. production of critical medicines featuring new pharmaceutical manufacturing investments in Ohio.
read more
Piramal Pharma Starts FY27 With 17% Revenue Growth, Higher EBITDA
Thursday, July 30, 2026
Piramal Pharma said it began FY27 with stronger revenue and margin expansion, driven by broad-based growth across its contract development and manufacturing, complex hospital generics and consumer healthcare businesses.
read more
More News
Featured Videos
Disabled_Documentary: A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
More Videos
Featured Products and Services
We're sorry, no matching articles were found. Please select different filter options and try your search again.
More Featured Products
Featured Articles
We're sorry, no matching articles were found. Please select different filter options and try your search again.
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »